Table 2 The islet characteristics.

From: Modified cell-permeable JNK inhibitors efficiently prevents islet apoptosis and improves the outcome of islet transplantation

 

n = 6

IE before purification

567,015 ± 135,277

IE after purification

433,544 ± 99,757

Embedded islets (%)

20.7 ± 3.3

Viability (%)

95.7 ± 0.4

Purity (%)

56.9 ± 7.0

Post-purification recovery (%)*

78.3 ± 6.8

Score

9.3 ± 0.2

  1. The data are expressed as the means ± SE.
  2. *Post-purification recovery (%) = IE after purification/(IE before purification) × 100.
Back to article page